The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
Open accessAbstract
Hepatocellular carcinoma (HCC) is an aggressive disease with a poor clinical outcome. The cancer stem cell (CSC) model states that tumour growth is powered by a subset of tumour stem cells within cancers. This model explains several clinical observations in HCC (as well as in other cancers), including the almost inevitable recurrence of tumours after initial successful chemotherapy and/or radiotherapy, as well as the phenomena of tumour dormancy and treatment resistance. The past two decades have seen a marked increase in research on the identification and characterization of liver CSCs, which has encouraged the design of novel diagnostic and treatment strategies for HCC. These studies revealed novel aspects of liver CSCs, including their heterogeneity and unique immunobiology, which are suggestive of opportunities for new research directions and potential therapies. In this Review, we summarize the present knowledge of liver CSC markers and the regulators of stemness in HCC. We also comprehensively describe developments in the liver CSC field with emphasis on experiments utilizing single-cell transcriptomics to understand liver CSC heterogeneity, lineage-tracing and cell-ablation studies of liver CSCs, and the influence of the CSC niche and tumour microenvironment on liver cancer stemness, including interactions between CSCs and the immune system. We also discuss the potential application of liver CSC-based therapies for treatment of HCC. The complexity of hepatocellular carcinoma (HCC) hinders effective treatment. Here, Lee and colleagues summarize cancer stem cell (CSC) origin and plasticity, CSC–immune system interactions and the effects of the microenvironmental niche on cancer stemness in HCC. Potential CSC-based therapies for HCC are also presented. Liver cancer stem cells (CSCs), a unique subset of hepatocellular carcinoma cells with stem cell features, dictate a hierarchical organization and contribute to treatment resistance and tumour recurrence. Early studies using cell-sorting and xenotransplantation techniques identified various liver CSC markers that have laid important groundwork for current research in the field. Lineage-tracing and cell-ablation studies in intact mouse tumours have provided insights into liver CSC plasticity, quiescence, renewal and treatment response. Liver CSCs are capable of sustaining tumours by altering intrinsic regulators that converge into common signalling pathways. Liver CSCs reside in dedicated niches where they interact reciprocally with cells and/or factors in the tumour microenvironment to regulate stemness. Understanding the key traits and mechanisms of liver CSC survival provides opportunities to improve patient outcomes through improving prognostic models and therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Chen, C.-L., Uthaya Kumar, D. B., Punj, V., Xu, J., Sher, L., Tahara, S. M., Hess, S., & Machida, K. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.004 · Cited by 388
RetractedReciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells
Chen, C.-L., Tsukamoto, H., Liu, J.-C., Kashiwabara, C., Feldman, D., Sher, L., Dooley, S., French, S. W., Mishra, L., Petrovic, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65859 · Cited by 162
RetractedCD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Barkal, A. A., Brewer, R. E., Markovic, M., Kowarsky, M., Barkal, S. A., Zaro, B. W., Krishnan, V., Hatakeyama, J., Dorigo, O., Barkal, L. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1456-0 · Cited by 1,385
Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor Cells
Ma, S., Chan, K., Hu, L., Lee, T. K., Wo, J. Y., Ng, I. O., Zheng, B., & Guan, X. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.025 · Cited by 1,192
Self-citationSignificance of CD90+ Cancer Stem Cells in Human Liver Cancer
Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P. W. K., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188
Yamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H., Jia, H., Ye, Q., Qin, L., Wauthier, E., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.004 · Cited by 1,149
Ruiz de Galarreta, M., Bresnahan, E., Molina-Sánchez, P., Lindblad, K. E., Maier, B., Sia, D., Puigvehi, M., Miguela, V., Casanova-Acebes, M., Dhainaut, M., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0074 · Cited by 912
Tumour evolution in hepatocellular carcinoma
Craig, A. J., von Felden, J., Garcia-Lezana, T., Sarcognato, S., & Villanueva, A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0229-4 · Cited by 823
Ma, S., Lee, T. K., Zheng, B.-J., Chan, K. W., & Guan, X.-Y. (2008) · Oncogene · doi:10.1038/sj.onc.1210811 · Cited by 775
Self-citationTargeted therapy for hepatocellular carcinoma
Huang, A., Yang, X.-R., Chung, W.-Y., Dennison, A. R., & Zhou, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00264-x · Cited by 739
Schrader, J., Gordon-Walker, T. T., Aucott, R. L., van Deemter, M., Quaas, A., Walsh, S., Benten, D., Forbes, S. J., Wells, R. G., & Iredale, J. P. (2011) · Hepatology · doi:10.1002/hep.24108 · Cited by 720
EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
Yamashita, T., Forgues, M., Wang, W., Kim, J. W., Ye, Q., Jia, H., Budhu, A., Zanetti, K. A., Chen, Y., Qin, L.-X., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6013 · Cited by 717
Wan, S., Zhao, E., Kryczek, I., Vatan, L., Sadovskaya, A., Ludema, G., Simeone, D. M., Zou, W., & Welling, T. H. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.039 · Cited by 675
Chiba, T., Kita, K., Zheng, Y.-W., Yokosuka, O., Saisho, H., Iwama, A., Nakauchi, H., & Taniguchi, H. (2006) · Hepatology · doi:10.1002/hep.21227 · Cited by 664
Wang, Y., He, L., Du, Y., Zhu, P., Huang, G., Luo, J., Yan, X., Ye, B., Li, C., Xia, P., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.03.003 · Cited by 634
Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells
Suetsugu, A., Nagaki, M., Aoki, H., Motohashi, T., Kunisada, T., & Moriwaki, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.128 · Cited by 609
CD13 is a therapeutic target in human liver cancer stem cells
Haraguchi, N., Ishii, H., Mimori, K., Tanaka, F., Ohkuma, M., Kim, H. M., Akita, H., Takiuchi, D., Hatano, H., Nagano, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42550 · Cited by 605
Lee, T. K. W., Castilho, A., Cheung, V. C. H., Tang, K. H., Ma, S., & Ng, I. O. L. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.06.005 · Cited by 586
Self-citationCharacterization of a Side Population of Cancer Cells from Human Gastrointestinal System
Haraguchi, N., Utsunomiya, T., Inoue, H., Tanaka, F., Mimori, K., Barnard, G. F., & Mori, M. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0282 · Cited by 569
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity
Yin, S., Li, J., Hu, C., Chen, X., Yao, M., Yan, M., Jiang, G., Ge, C., Xie, H., Wan, D., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22476 · Cited by 555
Heiss, M. M., Murawa, P., Koralewski, P., Kutarska, E., Kolesnik, O. O., Ivanchenko, V. V., Dudnichenko, A. S., Aleknaviciene, B., Razbadauskas, A., Gore, M., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25423 · Cited by 549
Schalper, K. A., Carleton, M., Zhou, M., Chen, T., Feng, Y., Huang, S.-P., Walsh, A. M., Baxi, V., Pandya, D., Baradet, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0856-x · Cited by 548
Yang, P., Li, Q.-J., Feng, Y., Zhang, Y., Markowitz, G. J., Ning, S., Deng, Y., Zhao, J., Jiang, S., Yuan, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.023 · Cited by 536
Ji, J., Yamashita, T., Budhu, A., Forgues, M., Jia, H., Li, C., Deng, C., Wauthier, E., Reid, L. M., Ye, Q., et al. (2009) · Hepatology · doi:10.1002/hep.22989 · Cited by 532
Cancer stem cells in the development of liver cancer
Yamashita, T., & Wang, X. W. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66024 · Cited by 525
Targeting Cancer Stemness in the Clinic: From Hype to Hope
Saygin, C., Matei, D., Majeti, R., Reizes, O., & Lathia, J. D. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.11.017 · Cited by 517
Calderaro, J., Petitprez, F., Becht, E., Laurent, A., Hirsch, T. Z., Rousseau, B., Luciani, A., Amaddeo, G., Derman, J., Charpy, C., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.003 · Cited by 479
He, G., Dhar, D., Nakagawa, H., Font-Burgada, J., Ogata, H., Jiang, Y., Shalapour, S., Seki, E., Yost, S. E., Jepsen, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.031 · Cited by 474
Umemura, A., He, F., Taniguchi, K., Nakagawa, H., Yamachika, S., Font-Burgada, J., Zhong, Z., Subramaniam, S., Raghunandan, S., Duran, A., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.006 · Cited by 463
Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations
Ma, S., Chan, K. W., Lee, T. K.-W., Tang, K. H., Wo, J. Y.-H., Zheng, B.-J., & Guan, X.-Y. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0035 · Cited by 459
Self-citationFan, Q.-M., Jing, Y.-Y., Yu, G.-F., Kou, X.-R., Ye, F., Gao, L., Li, R., Zhao, Q.-D., Yang, Y., Lu, Z.-H., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.008 · Cited by 458
Kurebayashi, Y., Ojima, H., Tsujikawa, H., Kubota, N., Maehara, J., Abe, Y., Kitago, M., Shinoda, M., Kitagawa, Y., & Sakamoto, M. (2018) · Hepatology · doi:10.1002/hep.29904 · Cited by 454
Activation of Hepatic Stem Cell Marker EpCAM by Wnt–β-Catenin Signaling in Hepatocellular Carcinoma
Yamashita, T., Budhu, A., Forgues, M., & Wang, X. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0908 · Cited by 446
Wang, F., Yuan, J.-H., Wang, S.-B., Yang, F., Yuan, S.-X., Ye, C., Yang, N., Zhou, W.-P., Li, W.-L., Li, W., et al. (2014) · Hepatology · doi:10.1002/hep.27239 · Cited by 440
Conigliaro, A., Costa, V., Lo Dico, A., Saieva, L., Buccheri, S., Dieli, F., Manno, M., Raccosta, S., Mancone, C., Tripodi, M., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0426-x · Cited by 436
Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration
Malato, Y., Naqvi, S., Schürmann, N., Ng, R., Wang, B., Zape, J., Kay, M. A., Grimm, D., & Willenbring, H. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59261 · Cited by 434
Zhu, Z., Hao, X., Yan, M., Yao, M., Ge, C., Gu, J., & Li, J. (2010) · International Journal of Cancer · doi:10.1002/ijc.24868 · Cited by 434
Finkin, S., Yuan, D., Stein, I., Taniguchi, K., Weber, A., Unger, K., Browning, J. L., Goossens, N., Nakagawa, S., Gunasekaran, G., et al. (2015) · Nature Immunology · doi:10.1038/ni.3290 · Cited by 433
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Yuen, K. C., Liu, L.-F., Gupta, V., Madireddi, S., Keerthivasan, S., Li, C., Rishipathak, D., Williams, P., Kadel, E. E., Koeppen, H., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0860-1 · Cited by 429
Yuan, S., Wang, J., Yang, F., Tao, Q., Zhang, J., Wang, L., Yang, Y., Liu, H., Wang, Z., Xu, Q., et al. (2016) · Hepatology · doi:10.1002/hep.27893 · Cited by 404
Sun, Y.-F., Xu, Y., Yang, X.-R., Guo, W., Zhang, X., Qiu, S.-J., Shi, R.-Y., Hu, B., Zhou, J., & Fan, J. (2013) · Hepatology · doi:10.1002/hep.26151 · Cited by 404
Organoid Models of Tumor Immunology
Yuki, K., Cheng, N., Nakano, M., & Kuo, C. J. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.06.010 · Cited by 402
Zhang, C., Huang, S., Zhuang, H., Ruan, S., Zhou, Z., Huang, K., Ji, F., Ma, Z., Hou, B., & He, X. (2020) · Oncogene · doi:10.1038/s41388-020-1303-7 · Cited by 393
Ma, S., Tang, K. H., Chan, Y. P., Lee, T. K., Kwan, P. S., Castilho, A., Ng, I., Man, K., Wong, N., To, K.-F., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.11.010 · Cited by 383
Self-citationIL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
Chan, L.-C., Li, C.-W., Xia, W., Hsu, J.-M., Lee, H.-H., Cha, J.-H., Wang, H.-L., Yang, W.-H., Yen, E.-Y., Chang, W.-C., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126022 · Cited by 382
Wnt/β-Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor Cells
Yang, W., Yan, H.-X., Chen, L., Liu, Q., He, Y.-Q., Yu, L.-X., Zhang, S.-H., Huang, D.-D., Tang, L., Kong, X.-N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6691 · Cited by 378
Identification of local and circulating cancer stem cells in human liver cancer
Yang, Z. F., Ngai, P., Ho, D. W., Yu, W. C., Ng, M. N. P., Lau, C. K., Li, M. L. Y., Tam, K. H., Lam, C. T., Poon, R. T. P., et al. (2008) · Hepatology · doi:10.1002/hep.22082 · Cited by 349
Single‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
Zheng, H., Pomyen, Y., Hernandez, M. O., Li, C., Livak, F., Tang, W., Dang, H., Greten, T. F., Davis, J. L., Zhao, Y., et al. (2018) · Hepatology · doi:10.1002/hep.29778 · Cited by 349
Kim, H., Choi, G. H., Na, D. C., Ahn, E. Y., Kim, G. I., Lee, J. E., Cho, J. Y., Yoo, J. E., Choi, J. S., & Park, Y. N. (2011) · Hepatology · doi:10.1002/hep.24559 · Cited by 341
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
Wang, Y., Chen, M., Wu, Z., Tong, C., Dai, H., Guo, Y., Liu, Y., Huang, J., Lv, H., Luo, C., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1440169 · Cited by 338
Lau, E. Y. T., Lo, J., Cheng, B. Y. L., Ma, M. K. F., Lee, J. M. F., Ng, J. K. Y., Chai, S., Lin, C. H., Tsang, S. Y., Ma, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.019 · Cited by 334
Self-citationMarquardt, J. U., Gomez-Quiroz, L., Arreguin Camacho, L. O., Pinna, F., Lee, Y.-H., Kitade, M., Domínguez, M. P., Castven, D., Breuhahn, K., Conner, E. A., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.018 · Cited by 309
LncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells
Zhu, P., Wang, Y., Wu, J., Huang, G., Liu, B., Ye, B., Du, Y., Gao, G., Tian, Y., He, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms13608 · Cited by 302
Shan, J., Shen, J., Liu, L., Xia, F., Xu, C., Duan, G., Xu, Y., Ma, Q., Yang, Z., Zhang, Q., et al. (2012) · Hepatology · doi:10.1002/hep.25745 · Cited by 296
Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis
Wang, X., Sun, W., Shen, W., Xia, M., Chen, C., Xiang, D., Ning, B., Cui, X., Li, H., Li, X., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.019 · Cited by 290
Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma
Yamashita, T., Honda, M., Nakamoto, Y., Baba, M., Nio, K., Hara, Y., Zeng, S. S., Hayashi, T., Kondo, M., Takatori, H., et al. (2013) · Hepatology · doi:10.1002/hep.26168 · Cited by 281
Bilusic, M., Heery, C. R., Collins, J. M., Donahue, R. N., Palena, C., Madan, R. A., Karzai, F., Marté, J. L., Strauss, J., Gatti-Mays, M. E., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0706-x · Cited by 274
Yang, X.-R., Xu, Y., Yu, B., Zhou, J., Qiu, S.-J., Shi, G.-M., Zhang, B.-H., Wu, W.-Z., Shi, Y.-H., Wu, B., et al. (2010) · Gut · doi:10.1136/gut.2008.176271 · Cited by 270
Tang, K. H., Ma, S., Lee, T. K., Chan, Y. P., Kwan, P. S., Tong, C. M., Ng, I. O., Man, K., To, K.-F., Lai, P. B., et al. (2012) · Hepatology · doi:10.1002/hep.24739 · Cited by 251
Self-citationWang, X. Q., Ongkeko, W. M., Chen, L., Yang, Z. F., Lu, P., Chen, K. K., Lopez, J. P., Poon, R. T. P., & Fan, S. T. (2010) · Hepatology · doi:10.1002/hep.23692 · Cited by 238
Budhu, A., Roessler, S., Zhao, X., Yu, Z., Forgues, M., Ji, J., Karoly, E., Qin, L., Ye, Q., Jia, H., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.054 · Cited by 238
lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal
Zhu, P., Wang, Y., Huang, G., Ye, B., Liu, B., Wu, J., Du, Y., He, L., & Fan, Z. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3235 · Cited by 231
Zhou, S., Yin, D., Hu, Z., Luo, C., Zhou, Z., Xin, H., Yang, X., Shi, Y., Wang, Z., Huang, X., et al. (2019) · Hepatology · doi:10.1002/hep.30630 · Cited by 226
Epigenetic Regulation of Cancer Stem Cell Marker Cd133 by Transforming Growth Factor-β
You, H., Ding, W., & Rountree, B. C. (2010) · Hepatology · doi:10.1002/hep.23544 · Cited by 221
Mima, K., Okabe, H., Ishimoto, T., Hayashi, H., Nakagawa, S., Kuroki, H., Watanabe, M., Beppu, T., Tamada, M., Nagano, O., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0299 · Cited by 215
Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment
Mu, X., Español-Suñer, R., Mederacke, I., Affò, S., Manco, R., Sempoux, C., Lemaigre, F. P., Adili, A., Yuan, D., Weber, A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77995 · Cited by 215
Lee, T. K.-W., Cheung, V. C.-H., Lu, P., Lau, E. Y. T., Ma, S., Tang, K. H., Tong, M., Lo, J., & Ng, I. O. L. (2014) · Hepatology · doi:10.1002/hep.27070 · Cited by 213
Self-citationCui, C.-P., Wong, C. C.-L., Kai, A. K.-L., Ho, D. W.-H., Lau, E. Y.-T., Tsui, Y.-M., Chan, L.-K., Cheung, T.-T., Chok, K. S.-H., Chan, A. C. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313264 · Cited by 212
Self-citationTovar, V., Cornella, H., Moeini, A., Vidal, S., Hoshida, Y., Sia, D., Peix, J., Cabellos, L., Alsinet, C., Torrecilla, S., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-309501 · Cited by 206
Tarao, K., Nozaki, A., Ikeda, T., Sato, A., Komatsu, H., Komatsu, T., Taguri, M., & Tanaka, K. (2019) · Cancer Medicine · doi:10.1002/cam4.1998 · Cited by 205
Wu, K., Ding, J., Chen, C., Sun, W., Ning, B.-F., Wen, W., Huang, L., Han, T., Yang, W., Wang, C., et al. (2012) · Hepatology · doi:10.1002/hep.26007 · Cited by 204
Yin, C., Lin, Y., Zhang, X., Chen, Y.-X., Zeng, X., Yue, H.-Y., Hou, J.-L., Deng, X., Zhang, J.-P., Han, Z.-G., et al. (2008) · Hepatology · doi:10.1002/hep.22510 · Cited by 201
Lo, J., Lau, E. Y. T., Ching, R. H. H., Cheng, B. Y. L., Ma, M. K. F., Ng, I. O. L., & Lee, T. K. W. (2015) · Hepatology · doi:10.1002/hep.27859 · Cited by 199
Self-citationCD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma
Piao, L. S., Hur, W., Kim, T.-K., Hong, S. W., Kim, S. W., Choi, J. E., Sung, P. S., Song, M. J., Lee, B.-C., Hwang, D., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.10.012 · Cited by 197
Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers
Oikawa, T., Kamiya, A., Zeniya, M., Chikada, H., Hyuck, A. D., Yamazaki, Y., Wauthier, E., Tajiri, H., Miller, L. D., Wang, X. W., et al. (2013) · Hepatology · doi:10.1002/hep.26159 · Cited by 195
Chiba, T., Miyagi, S., Saraya, A., Aoki, R., Seki, A., Morita, Y., Yonemitsu, Y., Yokosuka, O., Taniguchi, H., Nakauchi, H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5882 · Cited by 194
Liu, S., Li, N., Yu, X., Xiao, X., Cheng, K., Hu, J., Wang, J., Zhang, D., Cheng, S., & Liu, S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.046 · Cited by 193
Chen, Z.-Z., Huang, L., Wu, Y.-H., Zhai, W.-J., Zhu, P.-P., & Gao, Y.-F. (2016) · Nature Communications · doi:10.1038/ncomms12598 · Cited by 193
Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma
Kawai, T., Yasuchika, K., Ishii, T., Katayama, H., Yoshitoshi, E. Y., Ogiso, S., Kita, S., Yasuda, K., Fukumitsu, K., Mizumoto, M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1936 · Cited by 190
Octamer 4/microRNA‐1246 signaling axis drives Wnt/β‐catenin activation in liver cancer stem cells
Chai, S., Ng, K., Tong, M., Lau, E. Y., Lee, T. K., Chan, K. W., Yuan, Y., Cheung, T., Cheung, S., Wang, X., et al. (2016) · Hepatology · doi:10.1002/hep.28821 · Cited by 188
Self-citationWon, C., Kim, B., Yi, E. H., Choi, K., Kim, E., Jeong, J., Lee, J., Jang, J., Yoon, J., Jeong, W., et al. (2015) · Hepatology · doi:10.1002/hep.27968 · Cited by 187
Self-citationModeling Pathogenesis of Primary Liver Cancer in Lineage-Specific Mouse Cell Types
Holczbauer, Á., Factor, V. M., Andersen, J. B., Marquardt, J. U., Kleiner, D. E., Raggi, C., Kitade, M., Seo, D., Akita, H., Durkin, M. E., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.03.013 · Cited by 181
Ma, M. K. F., Lau, E. Y. T., Leung, D. H. W., Lo, J., Ho, N. P. Y., Cheng, L. K. W., Ma, S., Lin, C. H., Copland, J. A., Ding, J., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.015 · Cited by 177
Self-citationWang, R., Li, Y., Tsung, A., Huang, H., Du, Q., Yang, M., Deng, M., Xiong, S., Wang, X., Zhang, L., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722100115 · Cited by 172
Zhao, W., Wang, L., Han, H., Jin, K., Lin, N., Guo, T., Chen, Y., Cheng, H., Lu, F., Fang, W., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.025 · Cited by 171
Ho, D. W.-H., Tsui, Y.-M., Sze, K. M.-F., Chan, L.-K., Cheung, T.-T., Lee, E., Sham, P.-C., Tsui, S. K.-W., Lee, T. K.-W., & Ng, I. O.-L. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.06.002 · Cited by 168
Self-citationLai, K. K. Y., Kweon, S.-M., Chi, F., Hwang, E., Kabe, Y., Higashiyama, R., Qin, L., Yan, R., Wu, R. P., Lai, K., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.021 · Cited by 165
Xiao, P. G., Long, X., Zhang, L., Ye, Y., Guo, J., Liu, P., Zhang, R., Ning, J., Yu, W., Wei, F., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1440166 · Cited by 162
Ji, J., Eggert, T., Budhu, A., Forgues, M., Takai, A., Dang, H. T., Ye, Q., Lee, J., Kim, J. H., Greten, T. F., et al. (2015) · Hepatology · doi:10.1002/hep.27822 · Cited by 160
ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells
Zhu, P., Wang, Y., He, L., Huang, G., Du, Y., Zhang, G., Yan, X., Xia, P., Ye, B., Wang, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81979 · Cited by 160
Liu, C., Liu, L., Chen, X., Cheng, J., Zhang, H., Shen, J., Shan, J., Xu, Y., Yang, Z., Lai, M., et al. (2016) · Hepatology · doi:10.1002/hep.28509 · Cited by 159
Zhou, J., Zeng, Q., Wang, H., Zhang, B., Li, S., Nan, X., Cao, N., Fu, C., Yan, X., Jia, Y., et al. (2015) · Hepatology · doi:10.1002/hep.27887 · Cited by 156
Tummala, K. S., Brandt, M., Teijeiro, A., Graña‐Castro, O., Schwabe, R. F., Perna, C., & Djouder, N. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.059 · Cited by 154
Guo, W., Sun, Y., Shen, M., Ma, X.-L., Wu, J., Zhang, C.-Y., Zhou, Y., Xu, Y., Hu, B., Zhang, M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1753 · Cited by 153
Toh, T. B., Lim, J. J., Hooi, L., Rashid, M. B. M. A., & Chow, E. K. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.035 · Cited by 152
Xiang, D., Cheng, Z., Liu, H., Wang, X., Han, T., Sun, W. C., Li, X., Yang, W., Chen, C. Y., Xia, M., et al. (2016) · Hepatology · doi:10.1002/hep.28919 · Cited by 150
Self-citationHypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer
Ren, L., Yu, Y., Wang, L., Zhu, Z., Lu, R., & Yao, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.12409 · Cited by 149
Lineage fate of ductular reactions in liver injury and carcinogenesis
Jörs, S., Jeliazkova, P., Ringelhan, M., Thalhammer, J., Dürl, S., Ferrer, J., Sander, M., Heikenwalder, M., Schmid, R. M., Siveke, J. T., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78585 · Cited by 149
Wang, C., Yang, W. K., Yan, H., Luo, T., Zhang, J., Tang, L. V., Wu, F., Zhang, H., Yu, L., Zheng, L., et al. (2011) · Hepatology · doi:10.1002/hep.24675 · Cited by 149
Zhu, P., Wang, Y., Du, Y., He, L., Huang, G., Zhang, G., Yan, X., & Fan, Z. (2015) · Nature Communications · doi:10.1038/ncomms8122 · Cited by 146
Chen, H., Li, H., Li, J., Zhu, Z. G., Yin, S., Hao, X., Yao, M., Zheng, S.-S., & Gu, J. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn223 · Cited by 146
Govaere, O., Wouters, J., Petz, M., Vandewynckel, Y., den Eynde, K. V., den broeck, A. V., Verhulst, S., Dollé, L., Gremeaux, L., Ceulemans, A., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.011 · Cited by 144
Hayashi, H., Higashi, T., Yokoyama, N., Kaida, T., Sakamoto, K., Fukushima, Y., Ishimoto, T., Kuroki, H., Nitta, H., Hashimoto, D., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0291 · Cited by 142
Cheung, S., Cheung, P. F., Cheng, C. K. C., Wong, N. C. L., & Fan, S. T. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.049 · Cited by 142
The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma
Zeng, S. S., Yamashita, T., Kondo, M., Nio, K., Hayashi, T., Hara, Y., Nomura, Y., Yoshida, M., Hayashi, T., Oishi, N., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.024 · Cited by 140
Leung, H.-W., Leung, C. O. N., Lau, E. Y.-T., Chung, K. P. S., Mok, E. H. K., Lei, M. M. L., Leung, R. W. H., Tong, M., Keng, V. W., Ma, C., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0184 · Cited by 140
Self-citationLiu, C., Liu, L., Chen, X., Cheng, J., Zhang, H., Zhang, C., Shan, J., Shen, J., & Qian, C. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1236 · Cited by 139
Meylan, M., Petitprez, F., Lacroix, L., Tommaso, L. D., Roncalli, M. G., Bougoüin, A., Laurent, A., Amaddeo, G., Sommacale, D., Regnault, H., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2929 · Cited by 137
Li, L., Tang, J., Zhang, B.-H., Yang, W., LiuGao, M., Wang, R.-Y., Tan, Y., Fan, J.-L., Chang, Y.-X., Fu, J., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305715 · Cited by 136
Wu, J., Zhu, P., Lu, T., Du, Y., Wang, Y., He, L., Ye, B., Liu, B., Yang, L., Wang, J., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.015 · Cited by 134
Xiong, S., Wang, R., Chen, Q., Luo, J., Wang, J., Zhao, Z., Li, Y., Wang, Y., Wang, X., & Cheng, B. (2018) · PubMed · Cited by 133
Chen, Y., Wen, H., Zhou, C., et al. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.03.005 · Cited by 129
Park, D. J., Sung, P. S., Kim, J., Lee, G. W., Jang, J. W., Jung, E. S., Bae, S. H., Choi, J. Y., & Yoon, S. K. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000301 · Cited by 129
Liu, L., Dai, Y., Chen, J., Zeng, T., Li, Y., Chen, L., Zhu, Y.-H., Li, J., Ma, S., Xie, D., et al. (2013) · Hepatology · doi:10.1002/hep.26677 · Cited by 128
Self-citationMatrix stiffness-mediated effects on stemness characteristics occurring in HCC cells
You, Y., Zheng, Q., Dong, Y., Xie, X., Wang, Y., Wu, S., Zhang, L., Wang, Y., Xue, T., Wang, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8515 · Cited by 128
Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib
Tong, M., Che, N., Zhou, L., Luk, S. T.-C., Kau, P. W., Chai, S., Ngan, E., Lo, C. M., Man, K., Ding, J., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.034 · Cited by 128
Self-citationCheng, B. Y.-L., Lau, E. Y.-T., Leung, H.-W., Leung, C. O. N., Ho, N. P. Y., Gurung, S., Cheng, L. K., Lin, C. H., Lo, R. C., Ma, S., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2445 · Cited by 126
Self-citationCancer stemness in hepatocellular carcinoma: mechanisms and translational potential
Tsui, Y., Chan, L., & Ng, I. O. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0823-9 · Cited by 126
Lau, C. K., Yang, Z. F., Ho, D. W., Ng, M. N., Yeoh, G. C., Poon, R. T. P., & Fan, S. T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2127 · Cited by 122
Does the Hepatitis B Antigen HBx Promote the Appearance of Liver Cancer Stem Cells?
Arzumanyan, A. L., Friedman, T., Ng, I. O., Clayton, M. M., Lian, Z., & Feitelson, M. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3951 · Cited by 121
Lei, Z.-J., Wang, J., Xiao, H.-L., Guo, Y., Wang, T., Li, Q., Liu, L., Luo, X., Fan, L.-L., Li, L., et al. (2015) · Oncogene · doi:10.1038/onc.2015.129 · Cited by 120
Chan, L.-H., Zhou, L., Ng, K. Y., Wong, T. L., Lee, T. K., Sharma, R., Loong, J. H. C., Ching, Y. P., Yuan, Y., Xie, D., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.053 · Cited by 116
Self-citationLupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation
Lee, T. K., Castilho, A., Cheung, V. C. H., Tang, K. H., Ma, S., & Ng, I. O. (2010) · Hepatology · doi:10.1002/hep.24000 · Cited by 114
Self-citationQin, X., Suzuki, H., Honda, M., Okada, H., Kaneko, S., Inoue, I., Ebisui, E., Hashimoto, K., Carninci, P., Kanki, K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802279115 · Cited by 112
Mokkapati, S., Niopek, K., Huang, L., Cunniff, K. J., Ruteshouser, E. C., deCaestecker, M. P., Finegold, M. J., & Huff, V. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3275 · Cited by 111
METTL6 is a tRNA m 3 C methyltransferase that regulates pluripotency and tumor cell growth
Ignatova, V. V., Kaiser, S., Ho, J., Bing, X., Stolz, P., Tan, Y. X., Lee, C. L., Gay, F. P. H., Lastres, P. R., Gerlini, R., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz4551 · Cited by 111
Zhang, Y., Guan, D., Shi, J., Gao, H., Li, J., Zhao, J., Qiu, L., Liu, J., Li, N., Guo, W., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.009 · Cited by 110
Wang, Y., Wang, B., Xiao, S., Yang, L., & Chen, Q. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27436 · Cited by 110
Huang, J., Li, C., Wang, Y., Lv, H., Guo, Y., Dai, H., Wicha, M. S., Chang, A. E., & Li, Q. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.07.006 · Cited by 107
Zhi, X., Lin, L., Yang, S., Bhuvaneshwar, K., Wang, H., Gusev, Y., Lee, M., Kallakury, B., Shivapurkar, N., Cahn, K., et al. (2014) · Hepatology · doi:10.1002/hep.27558 · Cited by 107
Liu, L., Liu, C., Zhang, Q., Shen, J., Zhang, H., Shan, J., Duan, G., Guo, D., Chen, X., Cheng, J., et al. (2016) · Hepatology · doi:10.1002/hep.28690 · Cited by 105
Loong, J. H. C., Wong, T. L., Tong, M., Sharma, R., Zhou, L., Ng, K. Y., Yu, H.-J., Li, C.-H., Man, K., Lo, C. M., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143377 · Cited by 105
Self-citationGuo, W., Liu, S., Cheng, Y., Lü, L., Shi, J., Xu, G., Li, N., Cheng, K., Wu, M., Cheng, S., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3106 · Cited by 104
Chen, H., Kuo, T., Tseng, C., Ma, J., Yang, S., Yen, C., Yang, C., Sung, S., & Su, J. (2016) · Hepatology · doi:10.1002/hep.28773 · Cited by 104
Ang, C. H., Hsu, S. H., Guo, F., Tan, C. T., Yu, V. C., Visvader, J. E., Chow, P. K. H., & Fu, N. Y. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908099116 · Cited by 102
Pardee, A. D., Shi, J., & Butterfield, L. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400725 · Cited by 100
Kohga, K., Tatsumi, T., Takehara, T., Tsunematsu, H., Shimizu, S., Yamamoto, M., Sasakawa, A., Miyagi, T., & Hayashi, N. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.030 · Cited by 100
Kumar, D. B. U., Chen, C., Liu, J.-C., Feldman, D. E., Sher, L. S., French, S. W., DiNorcia, J., French, S. W., Naini, B. V., Junrungsee, S., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.11.002 · Cited by 100
Yamashita, T., Honda, M., Nio, K., Nakamoto, Y., Yamashita, T., Takamura, H., Tani, T., Zen, Y., & Kaneko, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4210 · Cited by 99
Rhee, H., Kim, H., Choi, J. H., Woo, H. G., Yoo, J. E., Nahm, J. H., Choi, J.-S., & Park, Y. N. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-0988 · Cited by 99
Nio, K., Yamashita, T., Okada, H., Kondo, M., Hayashi, T., Hara, Y., Nomura, Y., Zeng, S. S., Yoshida, M., Hayashi, T., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.009 · Cited by 98
Zhang, L., Sun, H., Zhao, F., Lü, P., Ge, C., Li, H., Hou, H., Yan, M., Chen, T., Jiang, G., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1013 · Cited by 95
Miltiadous, O., Sia, D., Hoshida, Y., Fiel, M. I., Harrington, A., Thung, S. N., Tan, P. S., Dong, H. F., Revill, K., Chang, C., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.025 · Cited by 94
Ali, N., Allam, H., May, R. J., Sureban, S. M., Bronze, M. S., Bader, T. F., Umar, S., ANANT, S., & Houchen, C. W. (2011) · Journal of Virology · doi:10.1128/jvi.05920-11 · Cited by 94
Li, L., Liu, Y., Guo, Y. H., Liu, B., Zhao, Y., Li, P., Song, F., Zheng, H., Yu, J., Song, T., et al. (2014) · Hepatology · doi:10.1002/hep.27543 · Cited by 94
Kopanja, D., Pandey, A., Kiefer, M. M., Wang, Z., Chandan, N., Carr, J. R., Franks, R. R., Yu, D., Guzman, G., Maker, A. V., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.023 · Cited by 93
Epigenetic reprogramming modulates malignant properties of human liver cancer
Raggi, C., Factor, V. M., Seo, D., Holczbauer, Á., Gillen, M. C., Marquardt, J. U., Andersen, J. B., Durkin, M. E., & Thorgeirsson, S. S. (2014) · Hepatology · doi:10.1002/hep.27026 · Cited by 92
Tong, M., Fung, T. M., Luk, S. T.-C., Ng, K. Y., Lee, T. K., Lin, C.-H., Yam, J. W. P., Chan, K. W., Ng, F., Zheng, B.-J., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.05.013 · Cited by 91
Self-citationGenetic lineage tracing analysis of the cell of origin of hepatotoxin‐induced liver tumors in mice
Shin, S., Wangensteen, K. J., Teta‐Bissett, M., Wang, Y. J., Mosleh‐Shirazi, E., Buza, E. L., Greenbaum, L. E., & Kaestner, K. H. (2016) · Hepatology · doi:10.1002/hep.28602 · Cited by 90
Leung, C. O. N., Tong, M., Chung, K. P. S., Zhou, L., Che, N., Tang, K. H., Ding, J., Lau, E. Y.-T., Ng, I. O., Ma, S., et al. (2019) · Hepatology · doi:10.1002/hep.30989 · Cited by 88
Self-citationPBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells
Han, H., Du, Y., Zhao, W., Li, S., Chen, D., Zhang, J., Liu, J., Suo, Z., Bian, X., Xing, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms9271 · Cited by 87
Wei, Z., Jia, J., Heng, G., Xu, H., Shan, J., Wang, G., Liu, C., Xia, J., Zhou, H., Wu, M. C., et al. (2019) · Hepatology · doi:10.1002/hep.30622 · Cited by 86
LGR5 marks targetable tumor-initiating cells in mouse liver cancer
Cao, W., Li, M., Liu, J., Zhang, S., Noordam, L., Verstegen, M. M. A., Wang, L., Ma, B., Li, S., Wang, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15846-0 · Cited by 86
Yang, X.-D., Kong, F.-E., Qi, L., Lin, J., Yan, Q., Loong, J. H. C., Xi, S., Zhao, Y., Zhang, Y., Yuan, Y., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01315-9 · Cited by 86
Self-citationRALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2
Wang, X., Wang, J., Tsui, Y., Shi, C., Wang, Y., Zhang, X., Yan, Q., Chen, M., Jiang, C., Yuan, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21828-7 · Cited by 86
Self-citationXu, M., Zhao, Z., Song, J., Lan, X., Lu, S., Chen, M., Wang, Z., Chen, W., Fan, X., Wu, F., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.01.008 · Cited by 85
Yang, H. D., Kim, H. S., Kim, S. Y., Na, M. J., Yang, G., Eun, J. W., Wang, H.-J., Cheong, J. Y., Park, W. S., & Nam, S. W. (2019) · Hepatology · doi:10.1002/hep.30657 · Cited by 85
Kong, F.-E., Li, G., Tang, Y.-Q., Xi, S., Loong, J. H. C., Li, M., Li, H., Cheng, W., Zhu, W., Mo, J.-Q., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb6282 · Cited by 85
Self-citationWu, R. P., Murali, R., Kabe, Y., French, S. W., Chiang, Y., Liu, S., Sher, L. S., Wang, C. C. C., Louie, S. G., & Tsukamoto, H. (2018) · Hepatology · doi:10.1002/hep.30071 · Cited by 82
Fekir, K., Dubois‐Pot‐Schneider, H., Désert, R., Daniel, Y., Glaise, D., Rauch, C., Morel, F., Fromenty, B., Musso, O. C., Cabillic, F., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2110 · Cited by 82
Lo, J. H. T., Lau, E. Y.-T., So, F. T. Y., Lu, P., Chan, V. S. F., Cheung, V. C. H., Ching, R. H. H., Cheng, B. Y.-L., Ma, M. K. F., Ng, I. O., et al. (2015) · Liver International · doi:10.1111/liv.12963 · Cited by 80
Self-citationMuramatsu, S., Tanaka, S., Mogushi, K., Adikrisna, R., Aihara, A., Ban, D., Ochiai, T., Irie, T., Kudo, A., Nakamura, N., et al. (2013) · Hepatology · doi:10.1002/hep.26345 · Cited by 77
Mitra, A., Yan, J., Xia, X., Zhou, S., Chen, J., Mishra, L., & Li, S. (2016) · Hepatology · doi:10.1002/hep.28951 · Cited by 74
Zhang, J., Han, C., Ungerleider, N., Chen, W., Song, K., Wang, Y., Kwon, H., Ma, W., & Wu, T. (2018) · Hepatology · doi:10.1002/hep.30153 · Cited by 73
Annexin A3 as a Potential Target for Immunotherapy of Liver Cancer Stem-Like Cells
Pan, Q., Pan, K., Wang, Q.-J., Weng, D., Zhao, J.-J., Zheng, H.-X., Zhang, X.-F., Jiang, S.-S., Lv, L., Tang, Y., et al. (2014) · Stem Cells · doi:10.1002/stem.1850 · Cited by 72
Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma
Re, O. L., Fusilli, C., Rappa, F., Haele, M. V., Douet, J., Pindjáková, J., Rocha, S. W. S., Pata, I., Valčíková, B., Uldrijan, S., et al. (2017) · Hepatology · doi:10.1002/hep.29519 · Cited by 71
Zhong, F., Cheng, X., Sun, S., & Zhou, J. (2017) · Oncology Reports · doi:10.3892/or.2017.5523 · Cited by 70
Zhong, M., Zhong, C. F., Cui, W., Wang, G., Zheng, G., Li, L., Zhang, J., Ren, R., Gao, H., Wang, T., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5670-9 · Cited by 69
Chua, H., Tsuei, D., Lee, P., Jeng, Y., Lu, J., Wu, J., Su, D., Chen, Y., Chien, C., Kao, P., et al. (2015) · Hepatology · doi:10.1002/hep.27996 · Cited by 68
Guan, D., Shi, J., Zhang, Y., Zhao, J., Long, L., Chen, T., Zhang, E., Feng, Y., Bao, W., Deng, Y., et al. (2015) · Hepatology · doi:10.1002/hep.28117 · Cited by 67
Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells
Song, Y., Pan, G., Chen, L., Ma, S., Zeng, T., Chan, T. H. M., Li, L., Lian, Q., Chow, R. K. K., Cai, X., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.010 · Cited by 67
Self-citationMatsumoto, T., Takai, A., Eso, Y., Kinoshita, K., Manabe, T., Seno, H., Chiba, T., & Marusawa, H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1800 · Cited by 67
Tan, J. L., Li, F., Yeo, J. Z. Z., Yong, K. J., Bassal, M. A., Ng, G. H., Lee, M. Y., Leong, C. Y., Tan, H. K., Wu, C.-S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.08.022 · Cited by 66
Self-citationAnnexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma
Pan, Q., Pan, K., Weng, D., Zhao, J., Zhang, X., Wang, D., Lv, L., Jiang, S., Zheng, H., & Xia, J. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22126 · Cited by 65
Wang, C., Wang, M.-D., Cheng, P., Huang, H., Dong, W., Zhang, W., Li, P., Lin, C., Pan, Z., Wu, M., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.493 · Cited by 64
Qian, Y., Chen, Y., Yang, W. K., Fu, J., Cao, J., Ren, Y., Zhu, J., Su, B., Luo, T., Zhao, X., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.042 · Cited by 63
Jiang, J., Ye, F., Yang, X. F., Zong, C., Gao, L., Yang, Y., Zhao, Q., Han, Z., & Wei, L. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.006 · Cited by 61
Zhao, X., Parpart, S., Takai, A., Roessler, S. K., Budhu, A., Yu, Z., Blank, M., Zhang, Y. E., Jia, H.-L., Ye, Q.-H., et al. (2015) · Oncogene · doi:10.1038/onc.2014.438 · Cited by 60
Zhang, H., Wang, M.-D., Zhou, X., Qin, C., Fu, G., Tang, L., Wu, H., Huang, S., Zhao, L., Zeng, M., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.023 · Cited by 60
A Soft Matrix Enhances the Cancer Stem Cell Phenotype of HCC Cells
Tian, B., Luo, Q., Ju, Y., & Song, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112831 · Cited by 59
Fan, H., Zhang, H., Pascuzzi, P. E., & ANDRISANI, O. M. (2015) · Oncogene · doi:10.1038/onc.2015.122 · Cited by 58
Sun, W. C., Ding, J., Wu, K., Ning, B., Wen, W., Sun, H., Han, T., Huang, L., Dong, L., Yang, W. K., et al. (2011) · Hepatology · doi:10.1002/hep.24530 · Cited by 57
CD133+ cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma
Liu, K., Hao, M., Ouyang, Y., Zheng, J., & Chen, D. (2017) · Scientific Reports · doi:10.1038/srep41499 · Cited by 57
Zhao, L., Yang, Y., Zhou, P., Ma, H., Zhao, X., He, X., Wang, T., Zhang, J., Liu, Y., & Zhang, T. (2015) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000086 · Cited by 56
Identification of MicroRNAs Specific for EpCAM+ Tumor Cells in Hepatocellular Carcinoma
Ji, J.-F., Zheng, X., Forgues, M., Yamashita, T., Wauthier, E., Reid, L., Wen, X.-Y., Song, Y., Wei, J. S., Khan, J., et al. (2015) · Hepatology · doi:10.1002/hep.27886 · Cited by 53
Loss of Xanthine Oxidoreductase Potentiates Propagation of Hepatocellular Carcinoma Stem Cells
Sun, Q., Zhang, Z., Lu, Y., Liu, Q., Xu, X., Xu, J., Liu, Y., Yu, H., Yu, D., & Sun, B. (2019) · Hepatology · doi:10.1002/hep.30978 · Cited by 52
Ng, K. Y., Shea, Q. T. K., Wong, T. L., Luk, S. T.-C., Tong, M., Lo, C. M., Man, K., Yun, J., Guan, X., Lee, T. K., et al. (2021) · Advanced Science · doi:10.1002/advs.202002483 · Cited by 52
Self-citationPromotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes
Kwon, Y., Bose, S. K., Steele, R., Meyer, K., Bisceglie, A. M. D., Ray, R. B., & RAY, R. K. (2015) · Journal of Virology · doi:10.1128/jvi.01946-15 · Cited by 45
Zheng, Y., Gong, J., Liu, X., Li, Y., & Zhen, Y. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22600 · Cited by 44
Cheung, P. F., Yip, C. W., Wong, N. C. L., Fong, D., Ng, L. W. C., Wan, A. M. Y., Wong, C. K., Cheung, T. T., Ng, I. O., Poon, R. T. P., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0096 · Cited by 42
Fan, H., Cui, Z., Zhang, H., Mani, S. K. K., Diab, A., Lefrançois, L., Farés, N., Merle, P., & ANDRISANI, O. M. (2016) · Oncogene · doi:10.1038/onc.2016.399 · Cited by 40
Toshiyama, R., Konno, M., Eguchi, H., Takemoto, H., Noda, T., Asai, A., Koseki, J., Haraguchi, N., Ueda, Y., Matsushita, K., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0406-x · Cited by 39
Wang, N., Li, M., Liu, Y., Yu, J. J., Ren, J., Zheng, Z., Wang, S., Yang, S., Yang, S., Liu, L., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.026 · Cited by 35
Takai, A., Dang, H. T., Oishi, N., Khatib, S. A., Martin, S. P., Dominguez, D. A., Luo, J., Bagni, R., Wu, X., Powell, K., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3015 · Cited by 32
Zhao, Z., Bai, S., Wang, R., Xiong, S., Li, Y., Wang, X., Chen, W., & Cheng, B. (2019) · Cancer Management and Research · doi:10.2147/cmar.s197634 · Cited by 27
Luk, S. T.-C., Ng, K. Y., Zhou, L., Tong, M., Wong, T. L., Yu, H., Lo, C., Man, K., Guan, X., Lee, T. K., et al. (2019) · Hepatology · doi:10.1002/hep.31020 · Cited by 25
Self-citationSun, J., Luo, Q., Liu, L., & Song, G. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.12.023 · Cited by 20
Effect of adipocyte-secreted factors on EpCAM+/CD133+ hepatic stem cell population
Karagonlar, Z. F., Koç, D., Şahin, E., Avcı, S. T., Yilmaz, M., Atabey, N., & Erdal, E. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.137 · Cited by 14
Lindhofer, H., Schoberth, A., Pelster, D., Hess, J., Herold, J., & Jäger, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.3014 · Cited by 12
Advances in surface markers of liver cancer stem cell
Zhang, J., Gong, L., Yan, Q., Zhou, N., Lee, V. H.-F., & Guan, X. (2019) · Hepatoma Research · doi:10.20517/2394-5079.2019.13 · Cited by 11
Self-citation
Cited by
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
Llovet, J. M., Pinyol, R., Kelley, R. K., El-Khoueiry, A., Reeves, H. L., Wang, X. W., Gores, G. J., & Villanueva, A. (2022) · Nature Cancer · doi:10.1038/s43018-022-00357-2 · Cited by 498
Wan, T., Zhong, J., Pan, Q., Zhou, T., Ping, Y., & Liu, X. (2022) · Science Advances · doi:10.1126/sciadv.abp9435 · Cited by 299
Zhang, S., Yuan, L., Danilova, L., Mo, G., Zhu, Q., Deshpande, A., Bell, A. T. F., Elisseeff, J., Popel, A. S., Anders, R. A., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01218-y · Cited by 140
Rosenberg, N., Van Haele, M., Lanton, T., Brashi, N., Bromberg, Z., Adler, H., Giladi, H., Peled, A., Goldenberg, D. S., Axelrod, J. H., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.07.029 · Cited by 72
Shen, P., Jia, Y., Zhou, W., Zheng, W., Wu, Y., Qu, S., Du, S., Wang, S., Shi, H., Sun, J., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.04.010 · Cited by 42
Metadata
- Authors
- Lee, T. K.-W., Guan, X.-Y., & Ma, S.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2021-09-09
- Volume
- 19
- Issue
- 1
- Pages
- 26-44
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W3188334818
- Cited by
- 460
- References
- 200
- FWCI
- 12.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.